HSBC Holdings’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$424K Sell
13,186
-736
-5% -$27.2K ﹤0.01% 2293
2025
Q4
$592K Buy
13,922
+14
+0.1% +$564 ﹤0.01% 2227
2025
Q3
$476K Sell
13,908
-10,471
-43% -$300K ﹤0.01% 2130
2025
Q2
$660K Buy
24,379
+2,677
+12% +$77.5K ﹤0.01% 2005
2025
Q1
$635K Buy
21,702
+10,618
+96% +$405K ﹤0.01% 1961
2024
Q4
$444K Buy
11,084
+1,406
+15% +$53.2K ﹤0.01% 2256
2024
Q3
$329K Sell
9,678
-3,015
-24% -$84.8K ﹤0.01% 2277
2024
Q2
$271K Sell
12,693
-297
-2% -$6.24K ﹤0.01% 2355
2024
Q1
$288K Buy
+12,990
New +$317K ﹤0.01% 2472
2021
Q1
Sell
-5,273
Closed -$261K 3151
2020
Q4
$261K Sell
5,273
-5,967
-53% -$277K ﹤0.01% 2660
2020
Q3
$370K Buy
11,240
+1,918
+21% +$61K ﹤0.01% 2123
2020
Q2
$241K Buy
+9,322
New +$232K ﹤0.01% 2242

Other funds holding VCYT

HSBC Holdings's VCYT Position: Q1 2026 in Review

HSBC Holdings reduced its Veracyte (VCYT) stake by 5.3% in Q1 2026, selling an estimated $27.2K and leaving 13,186 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #2293.

HSBC Holdings first reported a position in VCYT in Q2 2020 and has held it in 12 quarters since. The position peaked at $660K in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • HSBC Holdings held 13,186 shares of Veracyte worth $424K as of Q1 2026.
  • HSBC Holdings sold 736 Veracyte shares in Q1 2026, an estimated $27.2K.
  • Veracyte made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2293 holding.
  • HSBC Holdings first reported a position in Veracyte in Q2 2020 and has held it in 12 quarters since.
  • HSBC Holdings's Veracyte position peaked at $660K in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.